Table 2

Univariate analyses of clinical and laboratory parameters associated with the use of intravenous pulse methylprednisolone

Not responding to ribavirin+low dose steroid (n = 113)*Responding to ribavirin+low dose steroid (n = 25)*Odds ratio (95% CI)p value
*Values are mean (SD).
†Per 100 units increase.
‡Per 10 units increase.
Parameters at presentation
Age (years)39.9 (16.4)37.5 (17.8)1.01 (0.98 to 1.04)0.5
Male sex (%)48.7%44.0%1.21 (0.51 to 2.88)0.7
Duration between onset of symptom and treatment (days)5.4 (2.7)6.1 (2.8)0.91 (0.77 to 1.07)0.2
Platelet (×109/l)146 (58)175 (64)0.92 (0.86 to 0.99)‡0.03
Neutrophil count (×109/l)4 (2)3 (1)1.30 (0.98 to 1.74)0.1
Lymphocyte count (×109/l)1 (1)1 (1)0.82 (0.45 to 1.48)0.5
Activated partial thromboplastin time (s)42.3 (7.3)40.4 (10.4)1.04 (0.97 to 1.11)0.3
Sodium (mmol/l)135.5 (3.5)136.0 (2.5)0.95 (0.83 to 1.09)0.5
Urea (mmol/l)4.8 (5.4)4.4 (1.1)1.02 (0.91 to 1.14)0.7
Creatinine (μmol/l)101 (118)86 (22)1.01 (0.98 to 1.03)0.4
Alanine transferase (IU/l)28.8 (30.1)62.8 (158.1)1.01 (0.99 to 1.03)0.1
Creatinine kinase (U/l)390.1 (675.1)219.3 (272.3)1.08 (0.95 to 1.23)†0.2
Lactate dehydrogenase (U/l)370.4 (196.5)262.4 (114.4)1.56 (1.07 to 2.25)†0.02
Systolic blood pressure (mm Hg)117 (18)109 (11)1.36 (1.02 to 1.83)‡0.04
Diastolic blood pressure (mm Hg)62 (11)61 (11)1.07 (0.72 to 1.59)‡0.7
Pulse rate/min94 (14)92 (13)1.15 (0.84 to 1.57)‡0.4
C-reactive protein (mg/dl)51.9 (57.2)9.6 (10.3)2.18 (1.12 to 4.25)‡0.02
Parameters during treatment
Peak d-dimer (ng/ml)1184 (1201)1247 (2119)0.3
Lymphocyte count (nadir) (×109/l)0.3 (0.2)0.6 (0.4)<0.001
Creatinine kinase (peak) (U/l)515.7 (761.4)246.4 (268.8)0.1
Lactate dehydrogenase (peak) (U/l)468.6 (251.5)279.0 (109.5)0.001
Systolic blood pressure (nadir) (mm Hg)95 (9)94 (16)0.6
Diastolic blood pressure (nadir) (mm Hg)48 (7)49 (8)0.7
Pulse rate/min (peak)107 (15)99 (11)0.01
C-reactive protein (peak) (mg/dl)82.6 (83.8)13.1 (15.7)<0.001